A$ 2.5
Key Takeaways
Risk factor
Very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA,
Target Price
The average target price of IDX.AX is 3.3 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
